INOVIQ Ltd (ASX:IIQ)
Leearne Hinch is an accomplished executive in the biotechnology and life sciences sectors, currently serving as CEO of INOVIQ Ltd since November 2016, where innovative diagnostic technologies for cancer are developed. Prior experience includes founding Ingeneus Solutions Pty Ltd as Managing Director, offering consultancy services in strategic planning and commercialization within the biotech industry, and acting as Consultant & interim CEO for Eustralis Pharmaceuticals Ltd, focusing on neuroscience therapeutics. Hinch has held significant roles like COO at OBJ Limited, General Manager at Holista Colltech Limited, and Chief Sales & Marketing Officer at Chemeq Ltd, alongside marketing and sales management positions in veterinary and agricultural industries. Educational qualifications include a Bachelor's in Veterinary Medicine & Surgery and a Master's in Business Administration, both complemented by foundational studies in Veterinary Biology.
This person is not in any teams
INOVIQ Ltd (ASX:IIQ)
INOVIQ Ltd (ASX:IIQ) is a biotechnology company developing next-generation diagnostics and therapeutics for cancer. INOVIQ has commercialised its fast, efficient and scalable EXO-NET exosome isolation technology for biomarker discovery and diagnostics development, and the hTERT test as an adjunct test for bladder cancer. The company is advancing clinical-stage diagnostics for detection and monitoring of ovarian and breast cancers, and early-stage exosome therapeutics for solid tumours.